HSA
CALT

HBK Sorce Advisory’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

HBK Sorce Advisory’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-90,000
Closed -$104K – 845
2022
Q4 		$104K Buy
90,000
+45,000
+100% +$52K ﹤0.01% 690
2022
Q3 		$50K Buy
+45,000
New +$50K ﹤0.01% 517